Click image to zoom
Indian Economy
A general view shows medicines on display at a pharmacy in Srinagar, Jammu and Kashmir, on August 8, 2025. President Donald Trump tells CNBC's ''Squawk Box'' on Tuesday that planned tariffs on pharmaceuticals imported into the U.S. could eventually reach up to 250%, the highest rate he has threatened so far. Meanwhile, in an escalation of trade tensions between the United States and India, U.S. President Donald Trump, on August 6, 2025, signs an executive order imposing a 25 percent ad valorem tariff on all Indian imports into the United States. The ad valorem duty imposed in Executive Order 14257 applies in addition to the ad valorem duty imposed in section 2 of the order. This effectively means some categories of Indian exports may face a combined tariff burden of over 50 percent, depending on their classification. (Photo by Firdous Nazir/NurPhoto)
Photo Details
| Photo ID | #12625475 |
|---|---|
| Date Taken | |
| Location | N/A |
| Photographer | Firdous Nazir/NurPhoto |
| Category | Economy, Business and Finance |
| Copyright | © 2026 NurPhoto - Firdous Nazir/NurPhoto |
Related Keywords
medicines
pharmacy
Srinagar
Jammu and Kashmir
Donald Trump
CNBC
Squawk Box
tariffs
pharmaceuticals
U.S.
import
trade tensions
United States
India
executive order
ad valorem tariff
Indian imports
Executive Order 14257
duty
exports
classification
tariff burden
trade
August 2025
photo
Firdous Nazir
NurPhoto
President
highest rate
section 2
escalation
combined tariff
trade policy
international trade
economic impact
pharmaceutical industry.
2026 NurPhoto. All rights reserved.
This image is the property of NurPhoto and is protected under international copyright laws.
Similar Photos
View All
